Millipore Sigma Vibrant Logo

371955 H-7, Dihydrochloride - CAS 108930-17-2 - Calbiochem

A broad-based, cell-permeable, reversible, ATP-competitive serine/threonine kinase inhibitor.

SDB (Sicherheitsdatenblätter), Analysenzertifikate und Qualitätszertifikate, Dossiers, Broschüren und andere verfügbare Dokumente.

Synonyme: 1-(5-Isoquinolinesulfonyl)-2-methylpiperazine, 2HCl

Primary Target: MLCK
371955
Preis & Verfügbarkeit

Übersicht

Replacement Information

Key Spec Table

CAS #Empirical Formula
108930-17-2C₁₄H₁₇N₃O₂S · 2HCl

Preis & Verfügbarkeit

Bestellnummer VerfügbarkeitVerpackung St./Pkg. Preis Menge
371955-1MG
Verfügbarkeit wird abgerufen...
—
Eingeschränkte Verfügbarkeit Eingeschränkte Verfügbarkeit
Lieferbar 
Produkt wurde eingestellt
Begrenzter Lagerbestand
Bestätigung der Verfügbarkeit erforderlich
    Restmenge: Angebot folgt
      Restmenge: Angebot folgt
      Bitte erfragen
      Kontakt zum Kundenservice
      Contact Customer Service

      		 Kst.-Ampulle 1 mg
      Preis wird abgerufen...
      Preis nicht abrufbar
      Die Mindestmenge muss ein Vielfaches sein von
      Maximum Quantity is
      Bei Bestätigung Weitere Informationen
      Sie haben () gespart
       
      —
      Bitte erfragen
      		 —
      Description
      OverviewA broad-based, cell-permeable, reversible, ATP-competitive serine/threonine kinase inhibitor. Inhibits protein kinase A (Ki = 3.0 µM), myosin light chain kinase (Ki = 97 µM), protein kinase C (Ki = 6.0 µM), and protein kinase G (Ki = 5.8 µM). Induces apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukemia cells. Also inhibits telomerase activity in quercetin-, H-89-, or herbimycin A-treated NPC-076 cells.
      Catalogue Number371955
      Brand Family Calbiochem®
      Synonyms1-(5-Isoquinolinesulfonyl)-2-methylpiperazine, 2HCl
      References
      ReferencesKu, W.-C., et al. 1997. Biochem. Biophys. Res. Commun. 241, 730.
      Jarvis, W.D., et al. 1994. Cancer Res. 54, 1707.
      Bergstrand, H., et al. 1992. J. Pharmacol. Exp. Therap. 263, 1334.
      Gimond, C., et al. 1992. Exp. Cell Res. 203, 365.
      Quick, J., et al. 1992. Biochem. Biophys. Res. Commun. 187, 657.
      Bouli, N.M., and Davis, M. 1990. Brain Res. 525, 198.
      Takahashi, I., et al. 1990. J. Pharmacol. Exp. Ther. 255, 1218.
      Schachtele, C., et al. 1988. Biochem. Biophys. Res. Commun. 151, 542.
      Kawamoto, S., and Hidaka, H. 1984. Biochem. Biophys. Res. Commun. 125, 258.
      Product Information
      CAS number108930-17-2
      ATP CompetitiveY
      FormLight yellow lyophilized solid
      Hill FormulaC₁₄H₁₇N₃O₂S · 2HCl
      Chemical formulaC₁₄H₁₇N₃O₂S · 2HCl
      ReversibleY
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetMLCK
      Primary Target K<sub>i</sub>3.0 µM, 97 µM, 6.0 µM, 5.8 µM against protein kinase A , myosin light chain kinase, protein kinase C , and protein kinase G, respectively
      Purity≥98% by TLC
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage +2°C to +8°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, store in the refrigerator (4°C). Aqueous stock solutions are stable for up to 6 months at 4°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Bestellnummer GTIN
      371955-1MG 04055977213485

      Documentation

      H-7, Dihydrochloride - CAS 108930-17-2 - Calbiochem SDB

      Titel

      Sicherheitsdatenblatt (SDB) 

      H-7, Dihydrochloride - CAS 108930-17-2 - Calbiochem Analysenzertifikate

      TitelChargennummer
      371955

      Literatur

      Übersicht
      Ku, W.-C., et al. 1997. Biochem. Biophys. Res. Commun. 241, 730.
      Jarvis, W.D., et al. 1994. Cancer Res. 54, 1707.
      Bergstrand, H., et al. 1992. J. Pharmacol. Exp. Therap. 263, 1334.
      Gimond, C., et al. 1992. Exp. Cell Res. 203, 365.
      Quick, J., et al. 1992. Biochem. Biophys. Res. Commun. 187, 657.
      Bouli, N.M., and Davis, M. 1990. Brain Res. 525, 198.
      Takahashi, I., et al. 1990. J. Pharmacol. Exp. Ther. 255, 1218.
      Schachtele, C., et al. 1988. Biochem. Biophys. Res. Commun. 151, 542.
      Kawamoto, S., and Hidaka, H. 1984. Biochem. Biophys. Res. Commun. 125, 258.

      Broschüre

      Titel
      Caspases and other Apoptosis Related Tools Brochure
      Datenblatt

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision08-January-2010 RFH
      Synonyms1-(5-Isoquinolinesulfonyl)-2-methylpiperazine, 2HCl
      DescriptionA broad-based, cell-permeable, reversible, ATP-competitive serine-threonine kinase inhibitor. Potent inhibitor of myosin light chain kinase (Ki = 97 µM), protein kinase A (Ki = 3.0 µM), protein kinase C (Ki = 6 µM), and protein kinase G (Ki = 5.8 µM). Induces apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukemia cells. Also inhibits telomerase activity in quercetin-, H-89-, or herbimycin A-treated NPC-076 cells.
      FormLight yellow lyophilized solid
      Intert gas (Yes/No) Packaged under inert gas
      CAS number108930-17-2
      Chemical formulaC₁₄H₁₇N₃O₂S · 2HCl
      Structure formulaStructure formula
      Purity≥98% by TLC
      SolubilityH₂O (20 mg/ml). Further dilute with aqueous buffers just prior to use.
      Storage Protect from light
      +2°C to +8°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, store in the refrigerator (4°C). Aqueous stock solutions are stable for up to 6 months at 4°C.
      Toxicity Standard Handling
      ReferencesKu, W.-C., et al. 1997. Biochem. Biophys. Res. Commun. 241, 730.
      Jarvis, W.D., et al. 1994. Cancer Res. 54, 1707.
      Bergstrand, H., et al. 1992. J. Pharmacol. Exp. Therap. 263, 1334.
      Gimond, C., et al. 1992. Exp. Cell Res. 203, 365.
      Quick, J., et al. 1992. Biochem. Biophys. Res. Commun. 187, 657.
      Bouli, N.M., and Davis, M. 1990. Brain Res. 525, 198.
      Takahashi, I., et al. 1990. J. Pharmacol. Exp. Ther. 255, 1218.
      Schachtele, C., et al. 1988. Biochem. Biophys. Res. Commun. 151, 542.
      Kawamoto, S., and Hidaka, H. 1984. Biochem. Biophys. Res. Commun. 125, 258.

      Verwandte Produkte & Anwendungen

      Kategorien

      Life Science Research > Inhibitors and Biochemicals > Small Molecules & Inhibitors > Protein Phosphorylation / Dephosphorylation > Protein Kinase C (PKC) Inhibitors
      Life Science Research > Inhibitors and Biochemicals > Small Molecules & Inhibitors > Protein Phosphorylation / Dephosphorylation > Protein Kinase A (PKA; cAMP-Dependent Protein Kinase) Inhibitors
      Life Science Research > Inhibitors and Biochemicals > Small Molecules & Inhibitors > Protein Phosphorylation / Dephosphorylation > Protein Kinase G (PKG; cGMP-Dependent Protein Kinase) Inhibitors